IMA launches new inquiry to investigate EU Settlement Scheme application delays

Our updates ,
Public bodies ,

The Independent Monitoring Authority for the Citizens’ Rights Agreements (IMA) has launched an inquiry after receiving reports of citizens experiencing delays with their EU Settlement Scheme (EUSS) applications.  

The IMA has received information and complaints from people experiencing long wait times for a decision on their application. These include people waiting beyond estimated application processing times advised by the Home Office. 

As part of the inquiry, the IMA will investigate the impact these delays are having on citizens who have applied to the scheme. The IMA is calling on EU and EEA EFTA citizens and their family members who reside in the UK to share their experiences via an online survey to inform the inquiry.  *This survey has now closed. Thank you to all respondents*

The IMA is keen to hear real life examples from citizens about their experiences in applying to the EUSS and information about delays they may have faced in receiving a decision on their application. 

Pam Everett, IMA Director of Operational Delivery said: 

“The EU Settlement Scheme has received and concluded more than 7 million applications since its creation. We recognise that many of these were processed without issues, but we are aware that other citizens have experienced delays in receiving a decision. 

“We aim to understand how these delays are having an impact on citizens’ lives. It is therefore really important that we hear from as many people as possible to fully understand any issues and consider what next steps to take.” 

The IMA’s call for evidence will provide an understanding of the impact of delays, as well as generating narratives that will stem from citizens’ ‘lived experiences.’ Citizens can share their experiences via an online survey which will close on the 16 October 2023. 

Information about organisations which provide advice and support for EU and EEA EFTA citizens and their family members can be found on the IMA website.

The inquiry’s terms of reference can be found here.